Published in Cancer Weekly, October 26th, 2004
However, because the technology is much more expensive to deliver than the previous conformal therapy, three-dimensional conformal radiation therapy (3-D CRT), there have been concerns about cost-effectiveness.
A Fox Chase Cancer Center study presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Atlanta, looked at prostate cancer treatment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.